Tenax Therapeutics, Inc.
Tenax Therapeutics, Inc., a specialty pharmaceutical company, engages in identifying, developing, and commercializing products for cardiovascular and pulmonary diseases in the United States and Canada. It develops TNX-103 and TNX-102 (levosimendan) that …
Biotechnology
US, Morrisville [HQ]
Strategy & Leadership
All directors and officers of Tenax Therapeutics, Inc. are sourced directly from the SEC or manually.
For the SEC we either use the Form 3/4/5 or, even better extract the compensation for each leader out of the audited proxy statement (DEF-14A).
Each datapoint refers the most recent appearance of the corresponding person.
Officers & BofD Beta
For the SEC we either use the Form 3/4/5 or, even better extract the compensation for each leader out of the audited proxy statement (DEF-14A).
Total Compensation
Shows the total compensation per mentioned executive and board director.Each datapoint refers the most recent appearance of the corresponding person.
- No data, only available if we have DEF 14A compensations in place -
Officers
| Name & Position | Research | Last Appearance | ||
|---|---|---|---|---|
|
Rich Stuart
Chief Medical Officer
Also inside the BofD
|
12/12/24 [Form 4]
|
|||
|
Giordano Christopher Thomas
CEO
Also inside the BofD
|
12/12/24 [Form 4]
|
|||
|
Mcgauley Thomas
Interim CFO
|
12/06/24 [Form 3]
|
|||
|
Hoffman Lawrence R
Interim CFO
|
01/12/24 [Form 3]
|
|||
|
Lurier Eliot M
Interim CFO
|
11/04/21 [Form 3]
|
|||
|
Ditonno Anthony A
CEO
Also inside the BofD
|
07/08/21 [Form 4]
|
|||
|
Jebsen Michael B
CFO
|
01/12/21 [Form 4]
|
|||
Board of Directors (BofD)
| Name & Position | Research | Last Appearance | ||
|---|---|---|---|---|
|
Proehl Gerald T
Director
|
12/12/24 [Form 4]
|
|||
|
Hunter Robyn
Director
|
12/12/24 [Form 4]
|
|||
|
Doogan Declan
Director
|
12/12/24 [Form 4]
|
|||
|
Davidson Michael H.
Director
|
12/12/24 [Form 4]
|
|||
|
Almenoff June Sherie
Director
|
12/12/24 [Form 4]
|
|||
|
Mitchum James P.
Director
|
06/15/21 [Form 4]
|
|||